INNOCARE PHARMA LTD revenue for the last year amounted to 1.07 B HKD, the most of which — 1.09 B HKD — came from its highest performing source at the moment, Biopharmaceutical Research and Development, Manufacturing, Commercialization and Service, the year earlier bringing 816.08 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought INNOCARE PHARMA LTD 1.09 B HKD, and the year before that — 743.81 M HKD.